Genomics-guided treatment for people with prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial uses genetic test results from your prostate cancer to guide treatment choices. It may help find therapies that better match the specific gene changes in your cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed prostate cancer diagnosis from a biopsy or surgery results
- You are 18 years or older
- You can get or already have genetic test results from your cancer and/or blood showing certain gene changes
- Your test shows changes in one or more specified genes (PIK3, AKT, PALB2, BRIP1, RAD50, RAD51, RAD54, RB1, SPOP, Wnt/beta-catenin, CDK12, and/or MMR genes like MLH1/MSH2/MSH6/PMS2, and EPCAM)
- Your tumor may also qualify if it has high mutation level (TMB-high), such as 10+ mutations per megabase or bTMB 16+ mutations per megabase
- If you don’t have those results, you might still qualify if you’ve had an exceptionally strong response before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different drugs before prostate surgery based on a person's genetic profile. It aims to find better treatments for high-risk prostate cancer that hasn't spread yet.
This trial looks for specific DNA repair changes in men with prostate cancer. It tests if these genetic features can help guide treatment decisions. You may join if you have high-risk localized, newly metastatic, or advanced prostate cancer and have tissue available for testing.
This study tries to personalize prostate cancer care by matching treatment decisions to a person’s specific risk profile. You might be able to join if you have certain types of prostate cancer or a strong family history and meet health-function requirements.
This trial studies a blood test that looks for tumor DNA in men with high-risk or advanced prostate cancer. It may help doctors understand the cancer better and guide treatment decisions.
This trial looks at how inherited risk (family history or gene findings) relates to screening and treatment for prostate cancer. If you qualify, you may be offered prostate screening tests and follow-up to see how well risk information predicts next steps.
This trial is testing whether matching your cancer's specific genetic changes to a targeted treatment can help control metastatic prostate cancer that has stopped responding to standard hormone therapy and chemotherapy. You may receive a drug, a radioactive treatment, or a combination based on your tumor's molecular profile.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.